Doriano Fabbro

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

Simon D Harding, Joanna L Sharman, Elena Faccenda et al. · Nucleic Acids Research · 2017 · 1.6K citations · Full text

Clinical Immunology, New Ligands, Immunodeficiencies +17

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

Ellen Weisberg, Paul W. Manley, Werner Breitenstein et al. · Cancer Cell · 2005 · 1.5K citations · Full text

Molecular Pharmacology, Mutant Bcr-abl, Medicine +5

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity

Sauveur-Michel Maira, Frédéric Stauffer, Josef Brueggen et al. · Molecular Cancer Therapeutics · 2008 · 1.1K citations · Full text

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

Christopher Southan, Joanna L Sharman, Helen E. Benson et al. · Nucleic Acids Research · 2015 · 1K citations · Full text

Drug Target, Quantitative Pharmacology, Molecular Biology +22

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

S P H Alexander, Doriano Fabbro, Eamonn Kelly et al. · British Journal of Pharmacology · 2015 · 603 citations · Full text